GSK.XLON

GSK has reported that Blenrep achieved an important secondary outcome in the DREAMM-7 study.

Click here to view the full story on thefly.com, a trusted source for up-to-date financial news. The Fly is recognized for its market expertise and offers a live news feed for timely updates.

GSK has reported that Blenrep achieved an important secondary outcome in the DREAMM-7 study. Read More »

GSK, GSK.XLON

Could this AI growth stock, backed by Google, become the next Nvidia?

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

A healthcare company called Tempus AI (NASDAQ: TEM) that utilizes artificial intelligence (AI) to assist doctors in customizing patient care became a publicly traded company on 14 June. Established in 2015…

Could this AI growth stock, backed by Google, become the next Nvidia? Read More »

AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

A Google-supported artificial intelligence growth stock could be the next Nvidia.

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

On June 14, Tempus AI (NASDAQ: TEM), a healthcare company that utilizes artificial intelligence to assist doctors in customizing patient care, went public as a promising new growth stock. Established in 2015…

A Google-supported artificial intelligence growth stock could be the next Nvidia. Read More »

AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

Could this AI growth stock supported by Google be the next Nvidia?

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

Tempus AI, a healthcare company utilizing artificial intelligence to assist doctors in customizing patient care, became a publicly traded stock on June 14th. Established in 2015…

Could this AI growth stock supported by Google be the next Nvidia? Read More »

AI, AZN, AZN.XLON, GOOG, GOOGL, GRPN, GSK, GSK.XLON, NVDA, SMT.XLON, SOUN, TEM

Morning Brew reports on NIO’s revenue decline, Novavax’s gains in response to FDA review, and GSK’s acquisition of Elsie Biotech.

XLV Health Care, XLY Consumer Discretionary / / GSK, GSK Plc, GSK.XLON, NIO, NVAX

Stocks that are related include AAPL, NVAX, NIO, GSK, NVDA, MSFT, VNDA, IREN, MCRB, SMG, CORZ, with a 0.6% increase in HONGKONG’S HANG SENG.

Morning Brew reports on NIO’s revenue decline, Novavax’s gains in response to FDA review, and GSK’s acquisition of Elsie Biotech. Read More »

GSK, GSK Plc, GSK.XLON, NIO, NVAX

Morning Brew summarizes the latest news: NIO has reported a decrease in revenue, Novavax’s stock price is up following an FDA review, and GSK announces the acquisition of Elsie Biotech.

XLV Health Care, XLY Consumer Discretionary / / GSK, GSK Plc, GSK.XLON, NIO, NVAX

Stocks that are related include AAPL, NVAX, NIO, GSK, NVDA, MSFT, VNDA, IREN, MCRB, SMG, and CORZ, with a 0.6% increase in HONGKONG’S HANGSENG.

Morning Brew summarizes the latest news: NIO has reported a decrease in revenue, Novavax’s stock price is up following an FDA review, and GSK announces the acquisition of Elsie Biotech. Read More »

GSK, GSK Plc, GSK.XLON, NIO, NVAX

The GSK share price dropped by 10% in a single day, making it appear to be a rare opportunity to buy at a discounted price.

XLB Materials, XLF Financials, XLP Consumer Staples, XLV Health Care / / AstraZeneca PLC, AZN, AZN.XLON, GLEN.XLON, Glencore PLC, GSK, GSK Plc, GSK.XLON, Haleon PLC, HLN, HLN.XLON, JPM, JPMorgan Chase & Co., LE.HLN, UL, ULVR.XLON, Unilever PLC

The speaker enjoys purchasing stocks when they are down, so they bought shares of GSK right away when they saw the price had dropped by 9.53% on Monday. They have a habit of averaging down when investing.

The GSK share price dropped by 10% in a single day, making it appear to be a rare opportunity to buy at a discounted price. Read More »

AstraZeneca PLC, AZN, AZN.XLON, GLEN.XLON, Glencore PLC, GSK, GSK Plc, GSK.XLON, Haleon PLC, HLN, HLN.XLON, JPM, JPMorgan Chase & Co., LE.HLN, UL, ULVR.XLON, Unilever PLC

Morning Brew reports that Macy’s has increased its revenue forecast following strong first quarter results, while Lam Research has announced a $10 billion investment.

XLK Technology, XLV Health Care, XLY Consumer Discretionary / / GSK, GSK Plc, GSK.XLON, Lam Research Corporation, LRCX, M, Macy's Inc

Explore Warren Buffett’s stock picks by downloading the updated GuruFolio Report as of May 20, 2024. Related stocks include AAPL, LRCX, NVDA, PANW, SINGY, ZIM, GSK, V, MA, BABA, BIDU, JD.

Morning Brew reports that Macy’s has increased its revenue forecast following strong first quarter results, while Lam Research has announced a $10 billion investment. Read More »

GSK, GSK Plc, GSK.XLON, Lam Research Corporation, LRCX, M, Macy's Inc

Morning Brew reports that Macy’s has increased its revenue guidance following impressive Q1 results, while Lam Research has announced a $10 billion investment.

XLK Technology, XLV Health Care, XLY Consumer Discretionary / / GSK, GSK Plc, GSK.XLON, Lam Research Corporation, LRCX, M, Macy's Inc

Explore Warren Buffett’s stock picks by downloading the GuruFolio Report updated on 05/20/2024. The report includes related stocks such as AAPL, LRCX, NVDA, PANW, SINGY, ZIM, GSK, V, MA, BABA, BIDU, and JD.

Morning Brew reports that Macy’s has increased its revenue guidance following impressive Q1 results, while Lam Research has announced a $10 billion investment. Read More »

GSK, GSK Plc, GSK.XLON, Lam Research Corporation, LRCX, M, Macy's Inc

London’s FTSE slightly declines for the week following a period of record gains.

XLC Communication Services, XLF Financials, XLRE Real Estate, XLV Health Care / / Auto Trader Group PLC, AUTO.XLON, GSK, GSK Plc, GSK.XLON, Haleon PLC, HLN, HLN.XLON, Land Securities Group PLC, LAND.XLON, LE.HLN, Morgan Stanley, MS

London’s FTSE 100 closed the day and the week slightly down yesterday after reaching a series of record highs. The dip in the stock market occurred before an upcoming report on UK inflation that will impact short-term trends.

London’s FTSE slightly declines for the week following a period of record gains. Read More »

Auto Trader Group PLC, AUTO.XLON, GSK, GSK Plc, GSK.XLON, Haleon PLC, HLN, HLN.XLON, Land Securities Group PLC, LAND.XLON, LE.HLN, Morgan Stanley, MS

Sector Investors News and Insights

GSK has reported that Blenrep achieved an important secondary outcome in the DREAMM-7 study.

Could this AI growth stock, backed by Google, become the next Nvidia?

A Google-supported artificial intelligence growth stock could be the next Nvidia.

Could this AI growth stock supported by Google be the next Nvidia?

Morning Brew reports on NIO’s revenue decline, Novavax’s gains in response to FDA review, and GSK’s acquisition of Elsie Biotech.

Morning Brew summarizes the latest news: NIO has reported a decrease in revenue, Novavax’s stock price is up following an FDA review, and GSK announces the acquisition of Elsie Biotech.

The GSK share price dropped by 10% in a single day, making it appear to be a rare opportunity to buy at a discounted price.

Morning Brew reports that Macy’s has increased its revenue forecast following strong first quarter results, while Lam Research has announced a $10 billion investment.

Morning Brew reports that Macy’s has increased its revenue guidance following impressive Q1 results, while Lam Research has announced a $10 billion investment.

London’s FTSE slightly declines for the week following a period of record gains.

© 2024 ETF Sector

Sector Investors News and Insights

GSK.XLON

© 2024 ETF Sector

Subscribe to our Newsletter